Healthcare technology firm Abbott has been granted Conformité Européene approval for its Confirm RX ICM cardiac monitor. The device is designed to be used in the field by healthcare professionals and patients alike. The Confirm RX ICM will be launched during Q2 2017. The device is currently awaiting the approval of the US Food and Drug Administration.
Healthcare technology firm Abbott has been granted Conformité Européene approval for its Confirm RX ICM cardiac monitor. The device, which weighs three grams and is less than two inches long, is inserted into a patient's chest by a surgeon and wirelessly transmits continuous, encrypted data via an app to the Merlin.net Patient Care Network. The Confirm RX ICM will be launched during Q2 2017. The device is currently awaiting the approval of the US Food and Drug Administration.